Archive – Banking & Fintech

“Corporate villains” named and shamed

This content was published on Jan 25, 2006 The awards, which run parallel to the World Economic Forum (WEF) summit in the Swiss mountain resort of Davos, single out companies for “outstanding social and ecological irresponsibility”. Other companies nominated this year included Coca-Cola, the food multinational Nestlé, pharmaceutical company Novartis, as well as chemical firms Syngenta, Ciba Specialty and Bayer. The Public Eye…

WEF puts on its creative-thinking cap

This content was published on Jan 25, 2006 Davis says all possibilities must be exhausted to successfully meet the challenges of a shifting global landscape. swissinfo: This year’s theme – “The Creative Imperative” – what does it mean? Ged Davis: What we are saying is that today we have a situation where institutions don’t fit well with our needs, the capacity of leaders…

Lonza says it’s well on track for the future

This content was published on Jan 25, 2006 Lonza, which makes ingredients for the pharmaceutical industry, reported a sales increase of 15.5 per cent to SFr2.521 billion. Earnings were boosted by a 177-per-cent increase at Lonza’s exclusive synthesis and biopharmaceuticals unit, due to new contracts and high use of capacities at its flagship plant in the United States. Analysts polled by Reuters had…

Amgen decision disappoints and delights

This content was published on Jan 24, 2006 Environmentalists welcomed the move, while the economics ministry, regional authorities and the business community expressed disappointment. Amgen, the world’s biggest biotechnology group, announced on Tuesday that it had chosen a location in Ireland for its new production plant, giving Switzerland the cold shoulder. The company said it had opted for Ireland because of its thriving…

Amgen put off by Swiss complexity

This content was published on Jan 24, 2006 Professor Stéphane Garelli of IMD in Lausanne believes the Swiss can learn from Ireland’s one-stop advice system that helped persuade United States biotech giant Amgen to set up production there rather than in Switzerland. Amgen was also put off by opposition to its plans to build a SFr1.55-billion biotech plant on a greenfield site in…

Swiss lose out to Irish in jobs bonanza

This content was published on Jan 24, 2006 A greenfield site not far from the Swiss capital was in the running for the €1-billion (SFr1.55 billion) investment, despite protests from environmentalists. Amgen, with headquarters in California, has been looking for a manufacturing base for some time and Ireland won out over competition from Switzerland and Singapore to secure the facility. The authorities in…

Awards cast critical eye on companies

This content was published on Jan 24, 2006 Nominees this year include Coca-Cola, Nestlé, Novartis, Syngenta, Ciba Specialty Chemicals, Bayer AG and the Walt Disney Company. The Public Eye Awards ceremony will take place on January 25, the opening day of the WEF in the Swiss mountain resort, and will highlight the behaviour of particularly irresponsible organisations. Non-governmental organisations (NGOs) from around the…

Credit Suisse shuts door to clients from Iran

This content was published on Jan 23, 2006 The announcement comes just a day after its rival, UBS, announced it was severing ties with all clients in Iran. Credit Suisse said on Monday that it would not be taking on any more new business in the countries concerned, but current ties to clients would continue. The same rules apply to Cuba, Sudan, Myanmar…

Swiss want more spice in trade ties with India

This content was published on Jan 23, 2006 Deiss was speaking in the Indian capital, New Delhi, late on Monday after talks with the Indian commerce and trade minister, Kamal Nath. At a briefing for journalists after their meeting Kamal Nath said he hoped that small and medium-sized enterprises (SMEs) would soon have a better role to play in bilateral ties. “I have…

Not all industries will shine in 2006

This content was published on Jan 23, 2006 The bank predicts that the chemical, pharmaceutical and precision instrument sectors are the most likely to grow at an above-average rate in the medium term. It added that other sectors would be lucky to achieve average growth. Credit Suisse economists say that the signs that 2006 will be a good year are in place and…

Page 927 of 1641

First … 925 926 927 928 929 … Last

Archive – Banking & Fintech

Popular Stories

Most Discussed

Archive – Banking & Fintech

More

“Corporate villains” named and shamed

More

WEF puts on its creative-thinking cap

More

Lonza says it’s well on track for the future

More

Amgen decision disappoints and delights

More

Amgen put off by Swiss complexity

More

Swiss lose out to Irish in jobs bonanza

More

Awards cast critical eye on companies

More

Credit Suisse shuts door to clients from Iran

More

Swiss want more spice in trade ties with India

More

Not all industries will shine in 2006

Popular Stories

Most Discussed